BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Lung, Biofuel, Doxorubicin, rs3825942, NEUROG3, T cell receptor signaling pathway)
Bookmark Forward

QuickView for ondansetron (compound)


Genetic Markers

Most Correlated Genes

  1. HTR3A
  2. CGGBP1
  3. ABCA1
  4. JAG2
  5. CYP1B1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. response to organic substance
  2. regulation of nitrogen compound metabolic process
  3. cell differentiation
  4. positive regulation of protein metabolic process
  5. cytoplasmic vesicle
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drug Matrix In Vivo Toxicogenomic Study - Rat Intestine [Codelink]
  2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
  5. Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The Effect of Granisetron, Ondansetron, and Meperidine in Preventing Postoperative Shivering: Contro…
  2. The effect of intravenous ondansetron on QT interval in the emergency department.
  3. Effect of preoperative ondansetron on postoperative nausea in healthy dogs undergoing laparoscopic g…
  4. The Effect of Maropitant, Ondansetron and Metoclopramide on Dexmedetomidine-Induced Vomiting in Cats…
  5. Synergistic Antiemetic Effects of Nerolidol on Domperidone, Hyoscine, and Ondansetron: In Vivo and i…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Anti-shivering Effect of Ondansetron
  2. Ondansetron and the QT Interval In Adult Emergency Department Patients
  3. Ondansetron for the Management of Atrial Fibrillation
  4. CSF Pharmacokinetics of Ondansetron
  5. Effect of Ondansetron for Withdrawal Symptoms
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.